Induced CD45 Proximity Potentiates Natural Killer Cell Receptor Antagonism

Area of Science:

• Immunology
• Cell Biology
• Cancer Research

Background:

• Natural killer (NK) cells are crucial innate immune cells for combating pathogens and cancer.
• Inhibitory NK receptors (NKR), such as KIR and CD94/NKG2A, suppress NK cell activity, limiting antitumor and antiviral functions.
• Targeting these inhibitory pathways is a key strategy in cancer immunotherapy.

Purpose of the Study:

• To develop novel NKR antagonists that enhance NK and T cell activity.
• To investigate the synergistic effects of targeting multiple inhibitory pathways.
• To explore the mechanisms underlying enhanced immune cell activation.

Main Methods:

• Development of single-chain NKR antagonists linked to a VHH targeting CD45.
• In vitro assessment of NK and T cell potentiation compared to blocking antibodies.
• Investigation of crosstalk between NKG2A and Ly49 inhibitory receptors.
• Design of bispecific molecules targeting CD45-NKG2A and CD45-Ly49.

Main Results:

• CD45-linked NKR antagonists demonstrated superior potentiation of NK and T cell activity compared to NKR blocking antibodies alone.
• Synergistic enhancement of NK cell activation was observed with CD45-NKG2A and CD45-Ly49 bispecific molecules.
• Potential mechanisms include enhanced antagonism of inhibitory signaling, avidity effects, and CD45 segregation at the immune synapse.

Conclusions:

• A novel strategy using CD45-targeted NKR antagonists enhances NK and T cell activity.
• Bispecific molecules targeting NKG2A and Ly49 pathways offer synergistic immune-boosting effects.
• This approach holds promise for improving cancer immunotherapies by reactivating immune cells.